Nanoparticles for drug delivery

Details for Australian Patent Application No. 2004285553 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Rosenberger, Vered; Flashner-Barak, Moshe; Lerner, E. Itzhak; Moldavski, Naiomi

Agent FB Rice

Pub. Number AU-B-2004285553

PCT Pub. Number WO2005/041933

Priority 60/516,324 31.10.03 US

Filing date 28 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 10 December 2009

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/041933 Priority application(s): WO2005/041933

10 December 2009 Application Accepted

  Published as AU-B-2004285553

8 April 2010 Standard Patent Sealed

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285557-Medical device system

2004285547-Once-a-day, oral, controlled-release, oxycodone dosage forms